ITT (ITT) shares have shown steady gains over the past month, returning 7% and catching the attention of investors looking for consistent performers in the industrial sector. The company’s track ...
Patient Enrollment on Track in Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV), Topline Results from North ...
Are you a new Canadian investor and looking for a place to start? Here's an easy five-stock portfolio for a mix of growth, ...
WEARING THE JERSEY: Mikie Sherrill is in the bring-along-your-best-surrogate, get-out-the-vote, stick-the-landing part of her New Jersey gubernatorial campaign. Amid it all, Sherrill is pushing back ...
Strong operating performance delivered double-digit growth on both the top and bottom lineRaising full year 2025 guidance and issuing full year 2026 guidanceAnnounces business combination with Husky ...
Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® ...
Stoke Therapeutics, Inc. is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced business updates and reported ...
Detailed price information for Caribou Biosciences Inc (CRBU-Q) from The Globe and Mail including charting and trades.
Vertex, Inc. (NASDAQ: VERX) ("Vertex" or the "Company"), a leading global provider of indirect tax solutions, today announced financial results ...
Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback